| Financial Year |
March 31 2023 |
| Monetary Funds |
27,025,202,873.08 |
| Held-for-trading Financial Assets |
546,487,415.82 |
| Notes Receivable |
175,203,589.02 |
| Accounts Receivable |
661,629,370.63 |
| Advances to Suppliers |
3,930,849,287.79 |
| Other Receivables |
839,827,334.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
27,945,556,875.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,332,946,569.16 |
| Total Current Assets |
67,866,517,287.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
584,140,904.52 |
| Investment Properties |
162,125,216.49 |
| Fixed Assetes |
117,377,820,779.70 |
| Under-construction Projects |
33,109,495,450.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,210,400,158.40 |
| R&D expenses |
-- |
| Goodwill |
77,323,123.69 |
| Long-Term Deferred and Prepaid Expenses |
1,848,582,574.08 |
| Deferred Income Tax Assets |
777,065,033.54 |
| Other Non-Current Assets |
7,656,811,615.57 |
| Sub-Total of Non-Current Assets |
170,901,417,521.50 |
| Total Assets |
238,767,934,809.39 |
| Short-Term Loans |
60,313,918,674.73 |
| Trading Financial liabilities |
134,862,908.11 |
| Notes Payable |
16,588,798,399.48 |
| Accounts Payable |
15,705,202,524.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
318,362,061.11 |
| Taxes Payable |
1,307,521,477.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
513,588,884.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,098,479,094.26 |
| Other Current Liabilities |
3,112,032,389.13 |
| Sub-Total of Current Liabilities |
116,034,862,526.92 |
| Long-term Loans |
63,038,157,628.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,293,126,666.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,770,091.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,798,981,539.03 |
| Total Liabilities |
184,833,844,065.95 |
| Paid-In Capital(Or Share Stock) |
7,039,099,786.00 |
| Capital Surplus |
18,705,783,640.01 |
| Surplus Reserve |
905,565,700.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
27,299,509,897.22 |
| Minority Stockholder's Interest |
57,256,510.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,876,834,233.19 |
| Owner's Equity（Stockholder's Equity） |
53,934,090,743.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
238,767,934,809.39 |
